S&P 500 7,473.38 +0.40% NASDAQ 25,686.38 +0.70% DOW 51,981.20 +0.27% R2K 2,958.65 +0.55% VIX 17.74 -4.88% US 10Y 4.62 +0.48% DXY 101.12 +0.13% GOLD 4,057.40 +1.17% CRUDE 84.53 +1.56% BITCOIN 66,489.15 +1.93%
Next Bullish Trade
Sign in
ALKS

Alkermes plc NMS · ALKS

$51.95 +0.23 (+0.44%)
Neutral · +0.51σ
+ Compare Open in Sniper

Valuation

Market cap $8.7B
P/E (ttm) 57.7
Forward P/E 31.7
Beta (5y) 0.29
Shares out 166.7M
Div yield —

Profitability & returns

ROE 9.4%
Net margin 9.8%
FCF margin 9.0%
Debt / equity 0.90

Trading information

Last price $51.95
Day range $51.25 – $52.25
52-wk range $27.00 – $55.67
Avg volume 2.2M
RSI (2) 45.8
Trend zone Neutral
52-week range · today's price
$27.00$55.67

Company

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange NMS
Next earnings 2026-07-28

Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary commercial products for the treatment of opioid dependence, alcohol dependence, schizophrenia, bipolar I, and a pipeline of clinica…